Current Drug Targets
Title:Editorial: Advances in Psychopharmacological Treatment
Volume: 19 Issue: 8
Author(s): Ahmad Hatim Sulaiman and Ramli Musa
Affiliation:
Export Options
About this article
Cite this article as:
Sulaiman Hatim Ahmad and Musa Ramli , Editorial: Advances in Psychopharmacological Treatment, Current Drug Targets 2018; 19 (8) . https://dx.doi.org/10.2174/138945011908180518113546
DOI https://dx.doi.org/10.2174/138945011908180518113546 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
30
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Dietary Non-Fiber Carbohydrates on Composition and Function of Gut Microbiome in Monogastrics: A Review
Protein & Peptide Letters Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
Current Vascular Pharmacology Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry Non-Pharmacological Treatments in Autism Spectrum Disorders: An Overview on Early Interventions for Pre-Schoolers
Current Clinical Pharmacology Role of FAS in HIV Infection
Current HIV Research Inhibitor Design for Monoamine Oxidases
Current Pharmaceutical Design Modulation of Neurotransmitter Release by Carbon Monoxide at the Frog Neuro-Muscular Junction
Current Drug Metabolism Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study
Central Nervous System Agents in Medicinal Chemistry Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease
Current Drug Discovery Technologies Overview and Findings from the Religious Orders Study
Current Alzheimer Research Estimation of Affinity of HLA-A*0201 Restricted CTL Epitope Based on the SCORE Function
Protein & Peptide Letters Therapeutic Potential of DNA-aptamers Raised Against AGE-RAGE Axis in Diabetes-related Complications
Current Pharmaceutical Design Complement System in SLE as a Target for Antibodies
Current Rheumatology Reviews Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics
Current Pharmaceutical Design Evolving Therapeutic Targets in Ischemic Stroke: A Concise Review
Current Drug Targets T Cell Redirecting Therapies for Cancer Treatment
Current Cancer Drug Targets Protein Engineering for Improved Health: Technological Perspectives
Current Protein & Peptide Science Fluorinated Mechanism-Based Inhibitors: Common Themes and Recent Developments
Current Topics in Medicinal Chemistry Impact of the CD40-CD40L Dyad in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Genetic Variants in Diseases of the Extrapyramidal System
Current Genomics